BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...family office to develop preclinical cancer therapies that activate PP2A. Lassogen raises $4.5M seed for peptide therapeutics Lassogen Inc....
Items per page:
1 - 1 of 1
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...family office to develop preclinical cancer therapies that activate PP2A. Lassogen raises $4.5M seed for peptide therapeutics Lassogen Inc....
Items per page:
1 - 1 of 1